BioPharmSignal logoBioPharmSignal

Biotech News

PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026

PAVmed (PAVM)PAVmedEarnings

PAVM (PAVM) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is pavm.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

PAVMPAVmed2026-07-31 12:30 EST

PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026

PAVMPAVmed2026-07-30 12:30 EST

Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026

AEMDAethlon Medical2026-08-05 12:01 EST

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

EHCEncompass Health Corporation2026-07-09 20:30 EST

Encompass Health announces date of 2026 second quarter earnings call

XTNTXtant Medical2026-08-11 11:00 EST

Xtant Medical Reports Second Quarter 2026 Financial Results

BSXBoston Scientific2026-08-10 12:00 EST

Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results

SHCSotera Health2026-08-06 11:00 EST

Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

IRMDiRadimed2026-07-24 20:15 EST

IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026

CVRXCVRx2026-07-23 20:30 EST

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026

View all latest news

PAVmed

Diversified Medical Technology Portfolio PAVmed is a diversified commercial-stage medical technology company with businesses spanning diagnostic testing, digital health, and implantable medical devices. It develops products through both majority-owned subsidiaries and internally managed device programs. Lucid Esophageal Diagnostics Lucid...

Recent company news

PAVMPAVmed2026-08-14 12:00 EST

PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

PAVMPAVmed2026-08-13 12:00 EST

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

PAVMPAVmed2026-08-05 12:46 EST

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

PAVMPAVmed2026-08-04 12:30 EST

Lucid Diagnostics to Participate in Upcoming Investor Conferences

PAVMPAVmed2026-07-31 12:30 EST

PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026

Stock data

Close
5.18 USD
Market cap
42.95M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States